MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 10, 2006; DOI: 10.1124/mol.106.026690


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.106.026690v1
71/1/230    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dipace, C.
Right arrow Articles by Galli, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dipace, C.
Right arrow Articles by Galli, A.


Received for publication May 16, 2006.
Revised October 6, 2006.
Accepted for publication October 6, 2006.

AMPHETAMINE INDUCES A CAMKII-DEPENDENT REDUCTION IN NOREPINEPHRINE TRANSPORTER SURFACE EXPRESSION LINKED TO CHANGES IN SYNTAXIN 1A/TRANSPORTER COMPLEXES

Concetta Dipace 1, Uhna Sung 2, Francesca Binda 1, Randy Blakely 2, Aurelio Galli 2*

1 Vanderbilt University 2 Vanderbilt university

* Address correspondence to: E-mail: aurelio.galli{at}vanderbilt.edu

Abstract

Norepinephrine (NE) transporters (NETs) are high-affinity transport proteins that mediate the synaptic clearance of NE following vesicular release. NETs represent a major therapeutic target for antidepressants and are also targets of multiple psychostimulants including amphetamine (AMPH) and cocaine. Recently, we demonstrated that syntaxin 1A (SYN1A) regulates NET surface expression and, through binding to the transporter's NH2 terminus, regulates transporter catalytic function. AMPH induces NE efflux and may also regulate transporter trafficking. We monitored NET distribution and function in catecholaminergic cell lines (CAD) stably transfected with either full-length human NET (CAD-hNET) or with an hNET N-terminal deletion (CAD-hNET{Delta}28-47 cells). In hNET-CAD cells, AMPH causes a slow and small reduction of surface hNET with a modest increase in hNET/SYN1A associations at the plasma membrane. In contrast, in CAD-hNET{Delta}28-47 cells, AMPH induces a rapid and substantial reduction in surface hNET{Delta}28-47 accompanied by a large increase in plasma membrane hNET{Delta}28-47/SYN1A complexes. We also found that AMPH in CAD-hNET{Delta}28-47 cells induces a robust increase in cytosolic Ca2+ and concomitant activation of calcium/calmodulin-dependent protein kinase II (CaMKII). Inhibition of either the increase in intracellular Ca2+ or CaMKII activity blocks AMPH stimulated hNET{Delta}28-47 trafficking as well as the formation of hNET{Delta}28-47/SYN1A complexes. Here, we demonstrate that AMPH stimulation of CAMKII stabilizes a hNET/SYN1A complex. This hNET/SYN1A complex rapidly redistributes, upon AMPH treatment, when mechanisms supported by the transporter's NH2 terminus are eliminated.


Key words: Biogenic Amine, Amphetamines





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics